Synthesis, structure, and biological activity of certain 2-deoxy-.beta.-D-ribo-hexopyranosyl nucleosides and nucleotides

2-Deoxy-beta-D-ribo-hexopyranosyl nucleosides with adenine (2), hypoxanthine (17), guanine (23), cytosine (13), and uracil (7) as the aglycon were synthesized by the Lewis-acid catalyzed condensation of an appropriate trimethylsilylated heterocyclic base and 2-deoxy-1,3,4,6-tetrakis-O-(4-nitrobenzoy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 1987-06, Vol.30 (6), p.1044-1054
Hauptverfasser: Nord, L. Dee, Dalley, N. Kent, McKernan, Patricia A, Robins, Roland K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1054
container_issue 6
container_start_page 1044
container_title Journal of medicinal chemistry
container_volume 30
creator Nord, L. Dee
Dalley, N. Kent
McKernan, Patricia A
Robins, Roland K
description 2-Deoxy-beta-D-ribo-hexopyranosyl nucleosides with adenine (2), hypoxanthine (17), guanine (23), cytosine (13), and uracil (7) as the aglycon were synthesized by the Lewis-acid catalyzed condensation of an appropriate trimethylsilylated heterocyclic base and 2-deoxy-1,3,4,6-tetrakis-O-(4-nitrobenzoyl)-beta-D-ribo-hexopyranose+ ++ (5) to provide the desired beta anomers in good yield. When the synthesis of 7 via an SN2 displacement was attempted by reaction between silylated uracil and 2-deoxy-3,4,6-tris-O-(4-nitrobenzoyl)-alpha-D-ribo-hexopyranosyl bromide (8), the major product, 1-(2-deoxy-3,4,6-tris-O-(4-nitrobenzoyl)-alpha-D-ribo-hexopyranosyl)-2,4 - pyrimidinedione (9), had retained the alpha configuration at the anomeric carbon. The structures of both anomers of 1-(2-deoxy-D-ribo-hexopyranosyl)-2,4-pyrimidinedione were assigned by single-crystal X-ray methods. The anomeric configuration and conformation of other nucleosides were determined by proton magnetic resonance analysis of the 4-nitrobenzoylated nucleosides. Nucleoside 6'-monophosphates of 7, 13, and 2 and the 4',6'-cyclic monophosphate of 2 were also prepared. All 2'-deoxy-D-ribo-hexopyranosyl nucleosides and 6'-monophosphate derivatives were tested in vitro for antiviral and antitumor activity. The guanosine analogue 23 was moderately active against HSV-2 virus. The UMP analogue, 1-(2-deoxy-6-O-phosphono-beta-D-ribo-hexopyranosyl) -2,4-pyrimidinedione (28), demonstrated moderate activity against HSV-2 and parainfluenza 3 virus and was also active against L1210 (ID50 = 39 microM) and P388 (ID50 = 33 microM) leukemic cell lines. Two compounds, 6-amino-9-(2-deoxy-beta-D-ribo-hexopyranosyl)purine (2) and 9-(2-deoxy-beta-D-ribo-hexopyranosyl)-2,6-diaminopurine (24), were substrates for adenosine deaminase (EC 3.5.4.4) with Km values of 57 and 90 microM, respectively. 6-Amino-7-(2-deoxy-beta-D-ribo-hexopyranosyl)purine, 18, was a competitive inhibitor of ADase (Ki = 0.1 mM).
doi_str_mv 10.1021/jm00389a015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77540886</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77540886</sourcerecordid><originalsourceid>FETCH-LOGICAL-a315t-ed949e9ca63ae9394b0b84a09e5ccfd4e56552950ac11326ef9d5ff058dc157b3</originalsourceid><addsrcrecordid>eNptkU1v1DAQhi0EKtvCiTNSDggO1Is_4iQ-0pZSpJVA6iJxsybOhHrJxlvbQZt_T5asVhw4WaP30TvWM4S84mzJmeAfNlvGZKWBcfWELLgSjOYVy5-SBWNCUFEI-Zycx7hhE8eFPCNnUlVKM7kg-_uxTw8YXbzMYgqDTUPAywz6Jqud7_xPZ6HLwCb326Ux821mMSRwfSZog34_0mWNCZb0hgZXe_qAe78bA_Q-jl3WD7ZDH12D8W_lPKfD_II8a6GL-PL4XpDvt5_W13d09fXzl-uPKwqSq0Sx0blGbaGQgFrqvGZ1lQPTqKxtmxxVoZTQioHlXIoCW92otmWqaixXZS0vyNu5dxf844Axma2LFrsOevRDNGWpclZVxQS-n0EbfIwBW7MLbgthNJyZg2fzj-eJfn2sHeotNif2KHbK3xxziJPBdjJiXTxhlWDTmQ5L6Yy5mHB_iiH8MkUpS2XW3-7Nlbq7Wv9Y3Ro-8e9mHmw0Gz-EfnL33w_-AVJAomM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77540886</pqid></control><display><type>article</type><title>Synthesis, structure, and biological activity of certain 2-deoxy-.beta.-D-ribo-hexopyranosyl nucleosides and nucleotides</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Nord, L. Dee ; Dalley, N. Kent ; McKernan, Patricia A ; Robins, Roland K</creator><creatorcontrib>Nord, L. Dee ; Dalley, N. Kent ; McKernan, Patricia A ; Robins, Roland K</creatorcontrib><description>2-Deoxy-beta-D-ribo-hexopyranosyl nucleosides with adenine (2), hypoxanthine (17), guanine (23), cytosine (13), and uracil (7) as the aglycon were synthesized by the Lewis-acid catalyzed condensation of an appropriate trimethylsilylated heterocyclic base and 2-deoxy-1,3,4,6-tetrakis-O-(4-nitrobenzoyl)-beta-D-ribo-hexopyranose+ ++ (5) to provide the desired beta anomers in good yield. When the synthesis of 7 via an SN2 displacement was attempted by reaction between silylated uracil and 2-deoxy-3,4,6-tris-O-(4-nitrobenzoyl)-alpha-D-ribo-hexopyranosyl bromide (8), the major product, 1-(2-deoxy-3,4,6-tris-O-(4-nitrobenzoyl)-alpha-D-ribo-hexopyranosyl)-2,4 - pyrimidinedione (9), had retained the alpha configuration at the anomeric carbon. The structures of both anomers of 1-(2-deoxy-D-ribo-hexopyranosyl)-2,4-pyrimidinedione were assigned by single-crystal X-ray methods. The anomeric configuration and conformation of other nucleosides were determined by proton magnetic resonance analysis of the 4-nitrobenzoylated nucleosides. Nucleoside 6'-monophosphates of 7, 13, and 2 and the 4',6'-cyclic monophosphate of 2 were also prepared. All 2'-deoxy-D-ribo-hexopyranosyl nucleosides and 6'-monophosphate derivatives were tested in vitro for antiviral and antitumor activity. The guanosine analogue 23 was moderately active against HSV-2 virus. The UMP analogue, 1-(2-deoxy-6-O-phosphono-beta-D-ribo-hexopyranosyl) -2,4-pyrimidinedione (28), demonstrated moderate activity against HSV-2 and parainfluenza 3 virus and was also active against L1210 (ID50 = 39 microM) and P388 (ID50 = 33 microM) leukemic cell lines. Two compounds, 6-amino-9-(2-deoxy-beta-D-ribo-hexopyranosyl)purine (2) and 9-(2-deoxy-beta-D-ribo-hexopyranosyl)-2,6-diaminopurine (24), were substrates for adenosine deaminase (EC 3.5.4.4) with Km values of 57 and 90 microM, respectively. 6-Amino-7-(2-deoxy-beta-D-ribo-hexopyranosyl)purine, 18, was a competitive inhibitor of ADase (Ki = 0.1 mM).</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm00389a015</identifier><identifier>PMID: 3585903</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Adenosine Deaminase - analysis ; Animals ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - pharmacology ; Antiviral Agents - chemical synthesis ; Antiviral Agents - pharmacology ; Carbohydrates. Nucleosides and nucleotides ; Chemistry ; Condensed matter: structure, mechanical and thermal properties ; Exact sciences and technology ; Heterocyclic compounds ; Kinetics ; Magnetic Resonance Spectroscopy ; Mice ; Molecular Conformation ; Nucleosides - chemical synthesis ; Nucleosides - pharmacology ; Nucleosides, nucleotides and oligonucleotides ; Nucleotides - chemical synthesis ; Nucleotides - pharmacology ; Organic chemistry ; Organic compounds ; Physics ; Preparations and properties ; Protein Kinases - analysis ; Structure of solids and liquids; crystallography ; Structure of specific crystalline solids ; X-Ray Diffraction</subject><ispartof>Journal of medicinal chemistry, 1987-06, Vol.30 (6), p.1044-1054</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a315t-ed949e9ca63ae9394b0b84a09e5ccfd4e56552950ac11326ef9d5ff058dc157b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm00389a015$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm00389a015$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8205206$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3585903$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nord, L. Dee</creatorcontrib><creatorcontrib>Dalley, N. Kent</creatorcontrib><creatorcontrib>McKernan, Patricia A</creatorcontrib><creatorcontrib>Robins, Roland K</creatorcontrib><title>Synthesis, structure, and biological activity of certain 2-deoxy-.beta.-D-ribo-hexopyranosyl nucleosides and nucleotides</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>2-Deoxy-beta-D-ribo-hexopyranosyl nucleosides with adenine (2), hypoxanthine (17), guanine (23), cytosine (13), and uracil (7) as the aglycon were synthesized by the Lewis-acid catalyzed condensation of an appropriate trimethylsilylated heterocyclic base and 2-deoxy-1,3,4,6-tetrakis-O-(4-nitrobenzoyl)-beta-D-ribo-hexopyranose+ ++ (5) to provide the desired beta anomers in good yield. When the synthesis of 7 via an SN2 displacement was attempted by reaction between silylated uracil and 2-deoxy-3,4,6-tris-O-(4-nitrobenzoyl)-alpha-D-ribo-hexopyranosyl bromide (8), the major product, 1-(2-deoxy-3,4,6-tris-O-(4-nitrobenzoyl)-alpha-D-ribo-hexopyranosyl)-2,4 - pyrimidinedione (9), had retained the alpha configuration at the anomeric carbon. The structures of both anomers of 1-(2-deoxy-D-ribo-hexopyranosyl)-2,4-pyrimidinedione were assigned by single-crystal X-ray methods. The anomeric configuration and conformation of other nucleosides were determined by proton magnetic resonance analysis of the 4-nitrobenzoylated nucleosides. Nucleoside 6'-monophosphates of 7, 13, and 2 and the 4',6'-cyclic monophosphate of 2 were also prepared. All 2'-deoxy-D-ribo-hexopyranosyl nucleosides and 6'-monophosphate derivatives were tested in vitro for antiviral and antitumor activity. The guanosine analogue 23 was moderately active against HSV-2 virus. The UMP analogue, 1-(2-deoxy-6-O-phosphono-beta-D-ribo-hexopyranosyl) -2,4-pyrimidinedione (28), demonstrated moderate activity against HSV-2 and parainfluenza 3 virus and was also active against L1210 (ID50 = 39 microM) and P388 (ID50 = 33 microM) leukemic cell lines. Two compounds, 6-amino-9-(2-deoxy-beta-D-ribo-hexopyranosyl)purine (2) and 9-(2-deoxy-beta-D-ribo-hexopyranosyl)-2,6-diaminopurine (24), were substrates for adenosine deaminase (EC 3.5.4.4) with Km values of 57 and 90 microM, respectively. 6-Amino-7-(2-deoxy-beta-D-ribo-hexopyranosyl)purine, 18, was a competitive inhibitor of ADase (Ki = 0.1 mM).</description><subject>Adenosine Deaminase - analysis</subject><subject>Animals</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Antiviral Agents - chemical synthesis</subject><subject>Antiviral Agents - pharmacology</subject><subject>Carbohydrates. Nucleosides and nucleotides</subject><subject>Chemistry</subject><subject>Condensed matter: structure, mechanical and thermal properties</subject><subject>Exact sciences and technology</subject><subject>Heterocyclic compounds</subject><subject>Kinetics</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Mice</subject><subject>Molecular Conformation</subject><subject>Nucleosides - chemical synthesis</subject><subject>Nucleosides - pharmacology</subject><subject>Nucleosides, nucleotides and oligonucleotides</subject><subject>Nucleotides - chemical synthesis</subject><subject>Nucleotides - pharmacology</subject><subject>Organic chemistry</subject><subject>Organic compounds</subject><subject>Physics</subject><subject>Preparations and properties</subject><subject>Protein Kinases - analysis</subject><subject>Structure of solids and liquids; crystallography</subject><subject>Structure of specific crystalline solids</subject><subject>X-Ray Diffraction</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkU1v1DAQhi0EKtvCiTNSDggO1Is_4iQ-0pZSpJVA6iJxsybOhHrJxlvbQZt_T5asVhw4WaP30TvWM4S84mzJmeAfNlvGZKWBcfWELLgSjOYVy5-SBWNCUFEI-Zycx7hhE8eFPCNnUlVKM7kg-_uxTw8YXbzMYgqDTUPAywz6Jqud7_xPZ6HLwCb326Ux821mMSRwfSZog34_0mWNCZb0hgZXe_qAe78bA_Q-jl3WD7ZDH12D8W_lPKfD_II8a6GL-PL4XpDvt5_W13d09fXzl-uPKwqSq0Sx0blGbaGQgFrqvGZ1lQPTqKxtmxxVoZTQioHlXIoCW92otmWqaixXZS0vyNu5dxf844Axma2LFrsOevRDNGWpclZVxQS-n0EbfIwBW7MLbgthNJyZg2fzj-eJfn2sHeotNif2KHbK3xxziJPBdjJiXTxhlWDTmQ5L6Yy5mHB_iiH8MkUpS2XW3-7Nlbq7Wv9Y3Ro-8e9mHmw0Gz-EfnL33w_-AVJAomM</recordid><startdate>19870601</startdate><enddate>19870601</enddate><creator>Nord, L. Dee</creator><creator>Dalley, N. Kent</creator><creator>McKernan, Patricia A</creator><creator>Robins, Roland K</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19870601</creationdate><title>Synthesis, structure, and biological activity of certain 2-deoxy-.beta.-D-ribo-hexopyranosyl nucleosides and nucleotides</title><author>Nord, L. Dee ; Dalley, N. Kent ; McKernan, Patricia A ; Robins, Roland K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a315t-ed949e9ca63ae9394b0b84a09e5ccfd4e56552950ac11326ef9d5ff058dc157b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Adenosine Deaminase - analysis</topic><topic>Animals</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Antiviral Agents - chemical synthesis</topic><topic>Antiviral Agents - pharmacology</topic><topic>Carbohydrates. Nucleosides and nucleotides</topic><topic>Chemistry</topic><topic>Condensed matter: structure, mechanical and thermal properties</topic><topic>Exact sciences and technology</topic><topic>Heterocyclic compounds</topic><topic>Kinetics</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Mice</topic><topic>Molecular Conformation</topic><topic>Nucleosides - chemical synthesis</topic><topic>Nucleosides - pharmacology</topic><topic>Nucleosides, nucleotides and oligonucleotides</topic><topic>Nucleotides - chemical synthesis</topic><topic>Nucleotides - pharmacology</topic><topic>Organic chemistry</topic><topic>Organic compounds</topic><topic>Physics</topic><topic>Preparations and properties</topic><topic>Protein Kinases - analysis</topic><topic>Structure of solids and liquids; crystallography</topic><topic>Structure of specific crystalline solids</topic><topic>X-Ray Diffraction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nord, L. Dee</creatorcontrib><creatorcontrib>Dalley, N. Kent</creatorcontrib><creatorcontrib>McKernan, Patricia A</creatorcontrib><creatorcontrib>Robins, Roland K</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nord, L. Dee</au><au>Dalley, N. Kent</au><au>McKernan, Patricia A</au><au>Robins, Roland K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, structure, and biological activity of certain 2-deoxy-.beta.-D-ribo-hexopyranosyl nucleosides and nucleotides</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>1987-06-01</date><risdate>1987</risdate><volume>30</volume><issue>6</issue><spage>1044</spage><epage>1054</epage><pages>1044-1054</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>2-Deoxy-beta-D-ribo-hexopyranosyl nucleosides with adenine (2), hypoxanthine (17), guanine (23), cytosine (13), and uracil (7) as the aglycon were synthesized by the Lewis-acid catalyzed condensation of an appropriate trimethylsilylated heterocyclic base and 2-deoxy-1,3,4,6-tetrakis-O-(4-nitrobenzoyl)-beta-D-ribo-hexopyranose+ ++ (5) to provide the desired beta anomers in good yield. When the synthesis of 7 via an SN2 displacement was attempted by reaction between silylated uracil and 2-deoxy-3,4,6-tris-O-(4-nitrobenzoyl)-alpha-D-ribo-hexopyranosyl bromide (8), the major product, 1-(2-deoxy-3,4,6-tris-O-(4-nitrobenzoyl)-alpha-D-ribo-hexopyranosyl)-2,4 - pyrimidinedione (9), had retained the alpha configuration at the anomeric carbon. The structures of both anomers of 1-(2-deoxy-D-ribo-hexopyranosyl)-2,4-pyrimidinedione were assigned by single-crystal X-ray methods. The anomeric configuration and conformation of other nucleosides were determined by proton magnetic resonance analysis of the 4-nitrobenzoylated nucleosides. Nucleoside 6'-monophosphates of 7, 13, and 2 and the 4',6'-cyclic monophosphate of 2 were also prepared. All 2'-deoxy-D-ribo-hexopyranosyl nucleosides and 6'-monophosphate derivatives were tested in vitro for antiviral and antitumor activity. The guanosine analogue 23 was moderately active against HSV-2 virus. The UMP analogue, 1-(2-deoxy-6-O-phosphono-beta-D-ribo-hexopyranosyl) -2,4-pyrimidinedione (28), demonstrated moderate activity against HSV-2 and parainfluenza 3 virus and was also active against L1210 (ID50 = 39 microM) and P388 (ID50 = 33 microM) leukemic cell lines. Two compounds, 6-amino-9-(2-deoxy-beta-D-ribo-hexopyranosyl)purine (2) and 9-(2-deoxy-beta-D-ribo-hexopyranosyl)-2,6-diaminopurine (24), were substrates for adenosine deaminase (EC 3.5.4.4) with Km values of 57 and 90 microM, respectively. 6-Amino-7-(2-deoxy-beta-D-ribo-hexopyranosyl)purine, 18, was a competitive inhibitor of ADase (Ki = 0.1 mM).</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>3585903</pmid><doi>10.1021/jm00389a015</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 1987-06, Vol.30 (6), p.1044-1054
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_77540886
source MEDLINE; American Chemical Society Journals
subjects Adenosine Deaminase - analysis
Animals
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - pharmacology
Antiviral Agents - chemical synthesis
Antiviral Agents - pharmacology
Carbohydrates. Nucleosides and nucleotides
Chemistry
Condensed matter: structure, mechanical and thermal properties
Exact sciences and technology
Heterocyclic compounds
Kinetics
Magnetic Resonance Spectroscopy
Mice
Molecular Conformation
Nucleosides - chemical synthesis
Nucleosides - pharmacology
Nucleosides, nucleotides and oligonucleotides
Nucleotides - chemical synthesis
Nucleotides - pharmacology
Organic chemistry
Organic compounds
Physics
Preparations and properties
Protein Kinases - analysis
Structure of solids and liquids
crystallography
Structure of specific crystalline solids
X-Ray Diffraction
title Synthesis, structure, and biological activity of certain 2-deoxy-.beta.-D-ribo-hexopyranosyl nucleosides and nucleotides
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A05%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20structure,%20and%20biological%20activity%20of%20certain%202-deoxy-.beta.-D-ribo-hexopyranosyl%20nucleosides%20and%20nucleotides&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Nord,%20L.%20Dee&rft.date=1987-06-01&rft.volume=30&rft.issue=6&rft.spage=1044&rft.epage=1054&rft.pages=1044-1054&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm00389a015&rft_dat=%3Cproquest_cross%3E77540886%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77540886&rft_id=info:pmid/3585903&rfr_iscdi=true